CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Markets may open in the red following negative global cues

Karan Dsij 0 1220 Article rating: 5.0

Indian markets are likely to open lower on the back of pessimistic sentiments prevailing across Asian markets and as the US markets closed deep in the red overnight. Also, traders will prefer to remain light, ahead of the week-end. The IT stocks could be in focus today as some reports suggested that the Trump administration plans major changes in H1-B visa rules. The SGX Nifty indicates Nifty may open around the level of 10,332, down by 49 points.

IIFL Wealth Management Acquires Chennai-based Wealth Advisors India

Shohini Nath 0 2956 Article rating: 5.0

IIFL Wealth Management Ltd  announced it would acquire the entire share capital and the company of Chennai-based Wealth Advisors India Private Limited (Wealth Advisors).  IIFL Wealth will conclude the transaction for a consideration of INR 235 Crore. The transaction is subject to regulatory approvals. 

APL receives tentative USFDA approval, stock pierces its previous resistance

Bhagyashree Vivarekar 0 2747 Article rating: 5.0

Alembic Pharmaceuticals (APL) has received USFDA tentative approval for its ANDA Alogliptin tablets of 6.25 mg, 12.5 mg and 25 mg. The stock of Alembic Pharmaceuticals opened on a positive note with open and low as the same level, indicating optimism throughout the day. 

Markets may begin on a tepid note despite positive cues from Asian peers

Karan Dsij 0 977 Article rating: 3.7

Indian markets are likely to be begin on a lacklustre note and may move ahead based on how the US-Saudi Arabia standoff pans out during the day. The SGX Nifty is trading with a marginal gain of 13 points at 10,532. Among Nifty 50 stocks, Hero Motocorp and Infosys are set to declare their results today.   

Lupin receives tentative USFDA approval, stock tops Nifty pharma

Bhagyashree Vivarekar 0 1747 Article rating: 5.0

Lupin, the sixth largest pharma company by market capitalisation, received tentative US FDA approval for its generic Lurasidone Tablets of 20, 40, 60, 80 and 120 mg. Lupin which holds 8.8 per cent weightage in the Nifty pharma index was the top gainer in the index and surged 5 per cent on a closing basis. 

Benchmark indices bewildered, CPI and WPI moderately higher

Bhagyashree Vivarekar 0 1521 Article rating: 5.0

Continuing with the optimism shown on Friday, the Indian stock markets opened Monday’s session on a positive note but witnessed range-bound volatility during the day. Bounce back in the Indian rupee by 50 paise and Brent oil by 40 paise brought in some pessimism in the markets. The country reported WPI and CPI inflation. 

Cautious start likely following negative cues from Asian peers

Karan Dsij 0 895 Article rating: 5.0

The markets in India are expected to begin the truncated week on a cautious note as Asian markets are majorly trading in the negative terrain. The SGX Nifty is trading down by 4 points at 10,475. Among Nifty 50 stocks, IndusInd Bank and Indiabulls Housing Finance will announce their quarterly earnings today.

MFs prune stakes in NBFCs and HFCs

Gayathri Udyawar 0 1020 Article rating: 5.0

Mutual funds have reduced their stakes in most of the non-banking finance companies (NBFCs) and housing finance companies (HFCs) in September. The trigger for these exits was the defaults in repayments by group companies of Infrastructure Leasing & Financial Services (IL&FS). The subsequent ratings downgrades led to fears of a contagion in the sector.

Restoration and recharge benefits in health insurance policy

Prakash Patil 0 3617 Article rating: 3.5

Health insurance policies come with restoration and recharge benefits, but not many policyholders know what these benefits entail or can tell the difference between the two.  So, let us try to find out various kinds of restoration options, how recharge benefits the insured and the difference between restoration and recharge benefits.

Disinvesting the personal portfolio

Prakash Patil 0 1446 Article rating: 3.3

You must be aware of the divestment plans of the Government of India, wherein the government has divested its stake in various public sector undertakings (PSUs) and has thereby raised money from the markets.  The aim of the government’s divestment is to augments its revenue for the purpose of development.

Index trend and stocks in action

Gayathri Udyawar 0 727 Article rating: 5.0

Nifty has given a negative crossover in the oversold zone. Hence, if it continues to slide downwards, we hold 10100-10000 as the immediate supports, followed by 9950. However, Nifty has managed to close above its crucial level of 10200, and hence, if we see a bounce-back from the current levels, we hold 10270-10350, followed by 10480, as the resistances.

Markets may pare losses amid some relief among Asian peers

Gayathri Udyawar 0 589 Article rating: 5.0

Indian stock markets are likely to open on a flat to positive note with some bounce-back seen among Asian peers and the positive intra-day close in the previous session. The SGX Nifty is trading marginally higher by 0.3 per cent at 10308 level, indicating some relief in today’s trade. We have Hindustan Unilever and Karnataka Bank results on the plate today. TCS results came in with a mixed bag with the topline and EBUT outperforming, while the bottomline underperforming below expectations. 

Editorial

Kiran Dhawale 0 431 Article rating: No rating

The month of October usually brings some cheer in the Indian stock markets ahead of the festive seasons of Dussehra and Diwali. Leave apart the cheer or the consolidation, this time around, the markets have witnessed exodus of the market participants, majorly the FIIs. 

Data Bank

Sagar Bhosale 0 2393 Article rating: No rating

Value: Actual cost of the stock assigned by the security issuer and shown in the certificate.

Kerbside

Kiran Dhawale 0 2482 Article rating: No rating

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation

Reviews

Kiran Dhawale 0 1856 Article rating: No rating

In this edition, we have reviewed Natco Pharma and KSB Pumps. We suggest our reader-investors to HOLD Natco Pharma and KSB Pumps

RSS
First418419420421423425426427Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR